A place in pharma’s history of innovation
March 15, 2006Sales and Marketing prix galien
Registration has begun for entrants to the 2006 UK Prix Galien, which takes place at the Houses of Parliament this …
New NHS ratings take tougher line on financial performance
March 15, 2006New NHS performance ratings will put equal emphasis on a trust's quality of care and financial management. The independent watchdog, …
Crestor hailed as first drug to reverse cardiovascular disease
March 14, 2006Research and Development
Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …
Schering to fight takeover bid from Merck KGaA
March 14, 2006Sales and Marketing
A hostile takeover bid has been launched by Merck KGaA for rival German pharmaceutical company Schering.Both companies are enjoying strong …
We’re part of the solution, pharma tells Europe
March 13, 2006Sales and Marketing
Europe’s pharmaceutical industry body EFPIA has launched a new promotional campaign for the sector, which it hopes will raise awareness …
NHS chief executive resigns amid financial crisis
March 10, 2006NHS chief executive Nigel Crisp is to step down from the post as debts deepen in the health service.Significant improvements …
Bright future for NicOx after Pfizer glaucoma deal
March 10, 2006Research and Development
Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …
New Novartis blindness treatment filed in Europe
March 2, 2006Sales and Marketing AMD, Lucentis, Novartis
Lucentis, a new treatment for neovascular age-related macular degeneration or ‘wet AMD’ has been submitted by Novartis to the European …
Herceptin challenges put patient safety at risk, says survey
March 2, 2006NHS managers have warned that the sidelining of the normal regulatory process for new medicines will put patient safety at …
GSK launches Europe’s first rotavirus vaccine
March 1, 2006Sales and Marketing
GlaxoSmithKline has launched Rotarix in Europe, the first ever marketed vaccine against rotavirus gastroenteritis, a common but potentially lethal condition …
Bioenvision’s leukaemia treatment gains positive opinion
March 1, 2006Sales and Marketing
Bioenvision has received a positive opinion from the European Medicines Agency for Evoltra (clofarabine), the first drug specifically developed for …
Erbitux closer to head and neck cancer approval
March 1, 2006Sales and Marketing
Merck KGaA's targeted cancer treatment Erbitux has moved a step closer to receiving EU approval to extend its licence to …
Novartis files new Hepatitis B treatment in Europe
February 28, 2006Sales and Marketing
Novartis has filed its new hepatitis B treatment telbivudine in the European Union, and says it represents a potential new …
ABPI chief calls for ‘new rules of engagement’
February 23, 2006Sales and Marketing
UK pharmaceutical industry leader Richard Barker has called for a fundamental rethink in the way the industry and the NHS …
Gene silencing technology to be used in war against bird flu
February 23, 2006Sales and Marketing
Cutting edge technology will be used develop new drugs to treat dangerous strains of influenza, including the threat of a …
Wyeth to open clinical trial ‘Super Centres’
February 23, 2006Research and Development
Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …
Pfizer’s new blood infection drug Eraxis approved
February 23, 2006Research and Development
Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …
Sanofi’s wonder drug in limbo after regulator’s rejection
February 23, 2006Sales and Marketing
The future of Sanofi-Aventis' Acomplia is in serious doubt after regulators demanded more data for its use in weight loss, …
Pegasys recommended as front line hepatitis B treatment
February 23, 2006Sales and Marketing
Roche's Pegasys is set to be used more widely in England and Wales to treat hepatitis B following the release …
Tysabri trials restart after safety scare
February 20, 2006Research and Development
Clinical trials of Tysabri, the troubled multiple sclerosis treatment, are to begin again in the US after the FDA gave …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
